CALCA and migraine disorder: Thus, since a monoclonal antibody against CGRP was found to reduce concomitant colonic and bladder hypersensitivity and hyperpermeability, CGRP-targeting antibodies, in addition to migraine prevention, may represent a novel treatment approach to multi-organ abdominopelvic pain following injury or inflammation.